Enhanced resistance to bacterial infection in protegrin-1 transgenic mice

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 5, 2008, Pages 1812-1819

  Cheung, Queenie C K ^a   Turner, Patricia V ^b   Song, Cheng ^a   Wu, De ^a   Cai, Hugh Y ^c   MacInnes, Janet I ^b   Li, Julang ^a,c  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

^c UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEGRIN; PROTEGRIN 1;

ACTINOBACILLUS SUIS; ANIMAL CELL; ANIMAL DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; EXPERIMENTAL INFECTION; INFECTION PREVENTION; INFECTION RESISTANCE; LEUKOCYTE ACTIVATION; LEUKOCYTE DIFFERENTIAL COUNT; LIVESTOCK; LUNG LAVAGE; LUNG LESION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROVOCATION TEST; SPECIES COMPARISON; SURVIVAL RATE; SURVIVAL TIME; TRANSGENIC MOUSE; WILD TYPE;

ACTINOBACILLUS SUIS; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; BLOTTING, WESTERN; IMMUNITY, NATURAL; LUNG; MICE; MICE, TRANSGENIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SWINE;

EID: 42949110073     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01530-07     Document Type: Article

References (41)

1. Benincasa, M., M. Scocchi, S. Pacor, A. Tossi, D. Nobili, G. Basaglia, M. Busetti, and R. Gennaro. 2006. Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. J. Antimicrob. Chemother. 58:950-959.
2. Bowdish, D. M., D. J. Davidson, M. G. Scott, and R. E. Hancock. 2005. Immunomodulatory activities of small host defense peptides. Antimicrob. Agents Chemother. 49:1727-1732.
3. Bowdish, D. M., D. J. Davidson, D. P. Speert, and R. E. Hancock. 2004. The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. J. Immunol. 172:3758-3765.
4. Braff, M. H., M. A. Hawkins, A. Di Nardo, B. Lopez-Garcia, M. D. Howell, C. Wong, K. Lin, J. E. Streib, R. Dorschner, D. Y. Leung, and R. L. Gallo. 2005. Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. J. Immunol. 174:4271-4278.
5. Burnette, W. N. 1981. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 112:195-203.
6. Cole, A. M., J. Shi, A. Ceccarelli, Y. H. Kim, A. Park, and T. Ganz. 2001. Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. Blood 97:297-304.
7. Confer, A. W. 1993. Immunogens of Pasteurella. Vet. Microbiol. 37:353-368.
8. De, Y., Q. Chen, A. P. Schmidt, G. M. Anderson, J. M. Wang, J. Wooters, J. J. Oppenheim, and O. Chertov. 2000. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192:1069-1074.
9. Diamond, G., V. Kaiser, J. Rhodes, J. P. Russell, and C. L. Bevins. 2000. Transcriptional regulation of beta-defensin gene expression in tracheal epithelial cells. Infect. Immun. 68:113-119.
10. Dyce, P. W., R. J. DeVries, J. Walton, R. R. Hacker, and J. Li. 2003. Inducible expression of green fluorescent protein in porcine tracheal epithelial cells by the bovine tracheal antimicrobial peptide promoter. Biotechnol. Bioeng. 84:374-381.
11. Fattorini, L., R. Gennaro, M. Zanetti, D. Tan, L. Brunori, F. Giannoni, M. Pardini, and G. Orefici. 2004. In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis. Peptides 25:1075-1077.
12. Gudmundsson, G. H., and B. Agerberth. 1999. Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. J. Immunol. Methods 232:45-54.
13. Hancock, R. E., and H. G. Sahl. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24:1551-1557.
14. Jensen, L. B., A. M. Hammerum, F. Bager, and F. M. Aarestrup. 2002. Streptogramin resistance among Enterococcus faecium isolated from production animals in Denmark in 1997. Microb. Drug Resist. 8:369-374.
15. Klech, H., and C. Hutter. 1990. Clinical guidelines and indications for bronchoalveolar lavage (BAL): report of the European Society of Pneumology Task Group on BALF. Eur. Respir. J. 3:937-974.
16. Laviolette, M., M. Carreau, and R. Coulombe. 1988. Bronchoalveolar lavage cell differential on microscope glass cover: a simple and accurate technique. Am. Rev. Respir. Dis. 138:451-457.
17. Lee, P. H., T. Ohtake, M. Zaiou, M. Murakami, J. A. Rudisill, K. H. Lin, and R. L. Gallo. 2005. Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection. Proc. Natl. Acad. Sci. USA 102:3750-3755.
18. Lehrer, R. I., M. Rosenman, S. S. Harwig, R. Jackson, and P. Eisenhauer. 1991. Ultrasensitive assays for endogenous antimicrobial polypeptides. J. Immunol. Methods 137:167-173.
19. MacInnes, J. I., and R. Desrosiers. 1999. Agents of the "suis-ide diseases" of swine: Actinobacillus suis, Haemophilus parasuis, and Streptococcus suis. Can. J. Vet. Res. 63:83-89.
20. Mauch, C., and G. Bilkei. 2004. Actinobacillus suis, a potential cause of abortion in gilts and low parity sows. Vet. J. 168:186-187.
21. Miyakawa, Y., P. Ratnakar, A. G. Rao, M. L. Costello, O. Mathieu-Costello, R. I. Lehrer, and A. Catanzaro. 1996. In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis. Infect. Immun. 64:926-932.
22. Niyonsaba, F., K. Iwabuchi, A. Someya, M. Hirata, H. Matsuda, H. Ogawa, and I. Nagaoka. 2002. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 106:20-26.
23. Ojha, S., M. A. Hayes, P. V. Turner, and J. I. MacInnes. 2007. An experimental model of Actinobacillus suis infection in mice. Comp. Med. 57:340-348.
24. Ojha, S., M. Sirois, and J. I. MacInnes. 2005. Identification of Actinobacillus suis genes essential for the colonization of the upper respiratory tract of swine. Infect. Immun. 73:7032-7039.
25. Panyutich, A., J. Shi, P. L. Boutz, C. Zhao, and T. Ganz. 1997. Porcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins. Infect. Immun. 65:978-985.
26. Perregaux, D. G., K. Bhavsar, L. Contillo, J. Shi, and C. A. Gabel. 2002. Antimicrobial peptides initiate IL-1 beta posttranslational processing: a novel role beyond innate immunity. J. Immunol. 168:3024-3032.
27. Qu, X. D., S. S. Harwig, W. M. Shafer, and R. I. Lehrer. 1997. Protegrin structure and activity against Neisseria gonorrhoeae. Infect. Immun. 65:636-639.
28. Rennard, S. I., R. Aalbers, E. Bleecker, H. Klech, L. Rosenwasser, D. Olivieri, and Y. Sibille. 1998. Bronchoalveolar lavage: performance, sampling procedure, processing and assessment. Eur. Respir. J. Suppl. 26:13S-15S.
29. Rudolphus, A., J. Stolk, C. van Twisk, C. J. van Noorden, J. H. Dijkman, and J. A. Kramps. 1992. Detection of extracellular neutrophil elastase in hamster lungs after intratracheal instillation of E. coli lipopolysaccharide using a fluorogenic, elastase-specific, synthetic substrate. Am. J. Pathol. 141:153-160.
30. Salzman, N. H., D. Ghosh, K. M. Huttner, Y. Paterson, and C. L. Bevins. 2003. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422:522-526.
31. Shi, J., and T. Ganz. 1998. The role of protegrins and other elastase-activated polypeptides in the bactericidal properties of porcine inflammatory fluids. Infect. Immun. 66:3611-3617.
32. Steinberg, D. A., M. A. Hurst, C. A. Fujii, A. H. Kung, J. F. Ho, F. C. Cheng, D. J. Loury, and J. C. Fiddes. 1997. Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob. Agents Chemother. 41:1738-1742.
33. Steinstraesser, L., B. Tippler, J. Mertens, E. Lamme, H. H. Homann, M. Lehnhardt, O. Wildner, H. U. Steinau, and K. Uberla. 2005. Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides. Retrovirology 2:2.
34. Tamamura, H., T. Murakami, S. Horiuchi, K. Sugihara, A. Otaka, W. Takada, T. Ibuka, M. Waki, N. Yamamoto, and N. Fujii. 1995. Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity. Chem. Pharm. Bull (Tokyo) 43:853-858.
35. Tjabringa, G. S., D. K. Ninaber, J. W. Drijfhout, K. F. Rabe, and P. S. Hiemstra. 2006. Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors. Int. Arch. Allergy Immunol. 140:103-112.
36. Tzou, P., J. M. Reichhart, and B. Lemaitre. 2002. Constitutive expression of a single antimicrobial peptide can restore wild-type resistance to infection in immunodeficient Drosophila mutants. Proc. Natl. Acad. Sci. USA 99:2152-2157.
37. van Wetering, S., G. S. Tjabringa, and P. S. Hiemstra. 2005. Interactions between neutrophil-derived antimicrobial peptides and airway epithelial cells. J. Leukoc. Biol. 77:444-450.
38. Wegener, H. C., F. M. Aarestrup, P. Gerner-Smidt, and F. Bager. 1999. Transfer of antibiotic resistant bacteria from animals to man. Acta Vet. Scand. Suppl. 92:51-57.
39. Yan, H., and R. E. Hancock. 2001. Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrob. Agents Chemother. 45:1558-1560.
40. Zhao, C., T. Ganz, and R. I. Lehrer. 1995. The structure of porcine protegrin genes. FEBS Lett. 368:197-202.
41. Zhu, H., B. Tamot, M. Quinton, J. Walton, R. R. Hacker, and J. Li. 2004. Influence of tissue origins and external microenvironment on porcine foetal fibroblast growth, proliferative life span and genome stability. Cell Prolif. 37:255-266.